EULAR recommendations for the management of antiphospholipid syndrome in adults

2019/05/15 by Maria G Tektonidou, Maria G. Tektonidou, Laura Andréoli +31 · 32 citations
Medicine · #Systemic Lupus Erythematosus Research #Platelet Disorders and Treatments #Heparin-Induced Thrombocytopenia and Thrombosis

paper · pdf · doi:10.1136/annrheumdis-2019-215213

Citations

• 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

Cited by

• Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years
• CD40-CD40L inhibition attenuates platelet-neutrophil interaction and neutrophil extracellular trap release in primary antiphospholipid syndrome
• Complement activation in secondary thrombotic microangiopathies
• aPLs seroconversion in antiphospholipid syndrome: from definition to clinical relevance
• Antiphospholipid Syndrome: A Comprehensive Clinical Review
• Maternal and neonatal outcomes in obstetric antiphospholipid syndrome: a retrospective case-control study
• Effect of anti-nuclear antibody positivity with negative specific anti-extractable anti-nuclear antibodies on IVF and ICSI embryological outcomes: potential role of sperm concentration
• Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults. [europepmc]
• Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management. [europepmc]
• Role of direct oral anticoagulants in patients with kidney disease. [europepmc]
• Thrombophilia screening revisited: an issue of personalized medicine. [europepmc]
• Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology. [europepmc]
• Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. [europepmc]
• An update on the management of antiphospholipid syndrome. [europepmc]
• Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal. [europepmc]
• The interaction between the complement system and hemostatic factors. [europepmc]
• Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. [europepmc]
• Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository. [europepmc]
• 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. [europepmc]
• Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. [europepmc]
• Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. [europepmc]
• Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management. [europepmc]
• Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art. [europepmc]
• FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. [europepmc]
• Neurologic Manifestations of the Antiphospholipid Syndrome - an Update. [europepmc]
• Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines. [europepmc]
• Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. [europepmc]
• Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review. [europepmc]
• Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. [europepmc]
• Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances. [europepmc]
• Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials. [europepmc]
• Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update. [europepmc]